Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen.

Eyes treated using a reactive strategy had an increased lesion area and worse visual outcomes at 4 years. By contrast, the proactive regimen was associated with fewer recurrences of active disease, shrinkage of the lesion area, and better vision at four years.